These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 11602583)
1. The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo. Scott BR; McManus DC; Franklin V; McKenzie AG; Neville T; Sparks DL; Marcel YL J Biol Chem; 2001 Dec; 276(52):48716-24. PubMed ID: 11602583 [TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding. Minnich A; Collet X; Roghani A; Cladaras C; Hamilton RL; Fielding CJ; Zannis VI J Biol Chem; 1992 Aug; 267(23):16553-60. PubMed ID: 1644835 [TBL] [Abstract][Full Text] [Related]
3. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726 [TBL] [Abstract][Full Text] [Related]
4. Distinct central amphipathic alpha-helices in apolipoprotein A-I contribute to the in vivo maturation of high density lipoprotein by either activating lecithin-cholesterol acyltransferase or binding lipids. McManus DC; Scott BR; Frank PG; Franklin V; Schultz JR; Marcel YL J Biol Chem; 2000 Feb; 275(7):5043-51. PubMed ID: 10671546 [TBL] [Abstract][Full Text] [Related]
5. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. Laccotripe M; Makrides SC; Jonas A; Zannis VI J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897 [TBL] [Abstract][Full Text] [Related]
6. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins. Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480 [TBL] [Abstract][Full Text] [Related]
8. Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency. Chroni A; Duka A; Kan HY; Liu T; Zannis VI Biochemistry; 2005 Nov; 44(43):14353-66. PubMed ID: 16245952 [TBL] [Abstract][Full Text] [Related]
9. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice. Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988 [TBL] [Abstract][Full Text] [Related]
10. The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo. Chroni A; Koukos G; Duka A; Zannis VI Biochemistry; 2007 May; 46(19):5697-708. PubMed ID: 17447731 [TBL] [Abstract][Full Text] [Related]
11. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454 [TBL] [Abstract][Full Text] [Related]
12. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice. Reardon CA; Kan HY; Cabana V; Blachowicz L; Lukens JR; Wu Q; Liadaki K; Getz GS; Zannis VI Biochemistry; 2001 Nov; 40(45):13670-80. PubMed ID: 11695916 [TBL] [Abstract][Full Text] [Related]
13. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN. Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302 [TBL] [Abstract][Full Text] [Related]
14. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements. Cho KH; Durbin DM; Jonas A J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750 [TBL] [Abstract][Full Text] [Related]
15. Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity. Gorshkova IN; Mei X; Atkinson D J Lipid Res; 2018 Feb; 59(2):348-356. PubMed ID: 29208698 [TBL] [Abstract][Full Text] [Related]
16. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase. Clay MA; Pyle DH; Rye KA; Barter PJ J Biol Chem; 2000 Mar; 275(12):9019-25. PubMed ID: 10722751 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts. Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289 [TBL] [Abstract][Full Text] [Related]
18. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity. Sparks DL; Frank PG; Neville TA Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of scavenger receptor class B type I-mediated selective cholesteryl ester uptake from apoA-I(-/-) high density lipoprotein (HDL) by apolipoprotein A-I requires HDL reorganization by lecithin cholesterol acyltransferase. Temel RE; Parks JS; Williams DL J Biol Chem; 2003 Feb; 278(7):4792-9. PubMed ID: 12473673 [TBL] [Abstract][Full Text] [Related]
20. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles. Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]